Clinical trials
Alopecia Areata trials in the United States with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ASLAN Pharmaceuticals | 1 |
| AnaptysBio, Inc. | 1 |
| OM1, Inc. | 1 |
| Regeneris Medical | 1 |
| Sanguine Biosciences | 1 |
| The University of Texas Health Science Center, Houston | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alopecia Areata | 6 |
| Alopecia | 2 |
| Dermatitis, Atopic | 2 |
| Hidradenitis Suppurativa | 2 |
| Psoriasis | 2 |
| Vitiligo | 2 |
| Alzheimer Disease | 1 |
| Amyloidosis | 1 |
| Anemia, Sickle Cell | 1 |
| Arthritis | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.